Analyst Ratings For Craneware plc (LON:CRW)
Today, Peel Hunt raised its price target on Craneware plc (LON:CRW) to GBX 3,505 per share.
There are 2 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.
The current consensus rating on Craneware plc (LON:CRW) is Buy with a consensus target price of GBX 3,552.50 per share, a potential .
Some recent analyst ratings include
- 1/29/2019-Craneware plc (LON:CRW) had its Buy rating reiterated by Berenberg Bank with a GBX 3,600 price target
- 9/5/2017-Craneware plc (LON:CRW) had its Hold rating reiterated by N+1 Singer
About Craneware plc (LON:CRW)
Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company offers patient engagement solutions, such as InSight Medical Necessity, a software-as-a-service (SaaS) solution that provides medical necessity validation for United States payers and advance beneficiary notice creation; and Trisus Patient Payment, which provides hospitals and health systems to modernize patient payment. It also provides charge capture and pricing solutions, such as Chargemaster Toolkit, Chargemaster Toolkit Discovery Viewer, and Chargemaster Toolkit Corporate Discovery Viewer for capturing optimal legitimate reimbursement for providers; Physician Revenue Toolkit, a SaaS solution for managing physician group KPIs, charges, codes, RVUs, fee schedules, and related information; Pricing Analyzer, a SaaS solution that simplifies the price modelling process; Reference Plus, a SaaS solution to perform Chargemaster analysis; Pharmacy ChargeLink, a solution to enhance charge capture, pricing, and cost management; Trisus Supply, a solution that utilizes data to identify data gaps between the systems; and supporting modules, including Online Reference Toolkit, interface scripting module, and supplies assistant. In addition, the company provides Trisus Claims Informatics, a software that automates claim and coding reviews; InSight Audit, a Web-based audit management tool for healthcare organizations to manage government and commercial audits; and InSight Denials to analyze, track, trend, and report on denial data. Further, it provides Trisus Healthcare Intelligence, a cost analytics and resource efficiency platform; consulting and professional services; and sales and marketing, product development, and software development services. Craneware plc was founded in 1999 and is headquartered in Edinburgh, the United Kingdom.
Recent Trading Activity for Craneware plc (LON:CRW)
Shares of Craneware plc closed the previous trading session at 556,00 −104,00 3,91 % with shares trading hands.